Pharmaceutical companies privatise public knowledge and their growing power makes it almost impossible to do anything about the high prices of medicines. Big publishers and tech companies have succesfully lobbied for a copyright regime that makes it increasingly hard to share knowledge. In both cases, knowledge that was once public is commodified, enclosed and privatised. The struggle to keep knowledge in the public domain is the struggle for affordable health care and access to medicines. Slowly but surely a new discourse emerges that appreciates the collective and questions the existing paradigm. Commons Network is at the forefront of this new movement.
We are one of the instigators of the European Alliance for Affordable Medicines, we work with non-profit medicine makers and political parties to explore alternative models of biomedical innovation, we are building a coalition of NGO’s to counter the current hegemony of capitalist thinking in health care to re-invigorate the public approach to knowledge production.
Key words: Knowledge Commons, Access to Medicines, Big Pharma, Public Domain, Copyright, Common Good, Intellectual Property, Trade Agreements
Projects that are part of the Knowledge Commons and Access to Medicines Programme: